Tradestie Institutional Equity Comparison Engine

TLX vs CNTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLX Overall Edge

TLX Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Telix Pharmaceuticals Limited American Depositary Shares (TLX) driven by superior Valuation, Growth & Margin while CNTA counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, TLX trades at N/M Forward P/E with 6.2% operating margin (+22.3% YoY revenue) versus CNTA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TLX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNTA sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TLX
TLX N/M vs CNTA N/M Fwd P/E
Growth & Margin Winner TLX
Op Margin 6.2% vs 0.0% ยท YoY +22.3% vs +0.0%
Momentum & Technical Winner CNTA
1Y -5.5% vs +225.8% ยท 52W Pos 40% vs 100%
Options & Structure Winner CNTA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
TLX NASDAQ
Telix Pharmaceuticals Limited American Depositary Shares
Pharmaceutical Preparations
$8.98
-2.65% 1D
Market Cap $3.2B
1M Return -15.95%
1Y Return -5.52%
Forward P/E N/M
Unified AI Score
46.4 / 100 HOLD
Tech 64.0 Fund 62.0 Flow 50.0 Mom 60.0
CNTA NASDAQ
Centessa Pharmaceuticals plc American Depositary Shares
Pharmaceutical Preparations
$40.50
+0.8% 1D
Market Cap $6.2B
1M Return +1.73%
1Y Return +225.82%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TLX -5.52% CNTA +225.82% Spread: +48.59 pp (CNTA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TLX TTM Op. Margin: 6.2% CNTA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TLX vs CNTA. Trailing 12-month operating profitability (TLX 6.2% vs CNTA 0.0%) and valuation multiples (TLX N/M vs CNTA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TLX (5) vs CNTA (4)
Institutional Metric TLX CNTA Criterion Row Winner
Market Capitalization Scale $3.2B $6.2B Larger Scale CNTA
Trailing P/E Ratio Valuation 93.6x N/M Lower Multiple TLX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +22.3% +0.0% Higher Growth TLX
Operating Margin (TTM) Profitability 6.2% 0.0% Higher Margin TLX
Net Profit Margin Profitability 3.8% 0.0% Higher Margin TLX
Return on Equity (ROE) Capital Efficiency 7.4% -57.4% Higher ROE TLX
52-Week Range Position Momentum 40% ($6โ€“$13) 100% ($12โ€“$41) Stronger Trend CNTA
Beta / 30D Volatility Risk Regime 0.84ฮฒ ยท 62% Vol 1.31ฮฒ ยท 4% Vol Lower Realized Risk CNTA
Unified Institutional Score Composite Signal 46.4 / 100 (HOLD) 61.0 / 100 (BUY) Higher Composite CNTA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TLX vs CNTA Buy Guide
TLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CNTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CNTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TLX nor CNTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.